Official Newsletter of the Utah Poison Control Center 2010 • VOLUME 12 • ISSUE 4 T O D A Y NEW DRUGS FOR TREATMENT OF DIABETES - Dysplasia - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-06-02 15:25:44 Dipeptidyl peptidase-4 inhibitors Eli Lilly and Company Amides Anti-diabetic drugs Peptide hormones Exenatide Anti-diabetic medication Sitagliptin Saxagliptin Metformin Glucagon-like peptide-1 agonist Sulfonylurea		Official Newsletter of the Utah Poison Control Center 2010 • VOLUME 12 • ISSUE 4 T O D A Y NEW DRUGS FOR TREATMENT OF DIABETES Add to Reading List Source URL: poisoncontrol.utah.edu Download Document from Source Website File Size: 1,00 MB Share Document on Facebook

	Recall: Riomet™ (Metformin Hydrochloride Oral Solution): Microbial Contamination At PharmPix we are committed to the health and well-being of patients. It is for this reason that we inform that on November 27, 2017 the DocID: 1vpXt - View Document
	Microsoft Word - ALOGLIPTIN AND METFORMIN TABLETS_ALK334_R3_PI_CLEAN_12_5-500MG_12_5MG-1000MG_13June2016 .doc DocID: 1tj6K - View Document
	Microsoft Word - ALOGLIPTIN AND METFORMIN TABLETS_ALK334_R3_PI_CLEAN_12_5-500MG_12_5MG-1000MG_13June2016 .doc DocID: 1tcHG - View Document
	FDA Drug Safety Communication: FDA revises warnings regarding use of the diabetes medicine metformin in certain patients with reduced kidney function DocID: 1t6MV - View Document
	Schweizerische Gesellschaft für Endokrinologie und Diabetologie Société Suisse d’Endocrinologie et de Diabétologie Società Svizzera d’Endocrinologia e Diabetologia Societad Svizra d’Endocrinologia e Diabetolog DocID: 1qXHV - View Document